Injectable nanoparticle siRNA conjugate mediated gene silencing for glioblastoma stem cells and tumor cells

Loading...
Thumbnail Image

Date

item.page.authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Nanoparticle based siRNA conjugate is a promising therapeutic approach as indicated by recent FDA approval. In this thesis, we have investigated the development and in vitro / in vivo characterization of multiple siRNA-loaded self-assembled nanoparticle gel (NPG) that can be injected locally into the brain (tumor resected cavity); for combinatorial silencing of genes associated with glioma stem cells (GSC). GSCs are characterized by deregulated stem-cell signaling, efficient drug-efflux properties, and the ability to scavenge reactive oxygen species. We used a clinically approved cationic peptide to orchestrate the self-assembly of multiple siRNA sequences targeting FAK, NOTCH-1, and SOX-2 into a single nanoparticle (n-siRNAFAK+NOTCH-1+SOX-2), which is further made into a locally injectable-gel using hyaluronic acid. The nanoparticles showed an average size of ~ 250 nm with ~ 95% siRNA loading efficiency and ~ 95.5% cellular uptake in GSCs characterized by CD133, Nestin, SOX-2, and NOTCH-1 expression. Silencing of FAK, NOTCH-1 or SOX-2 with their respective singular n-siRNA sequence resulted in down-regulation of specific targets but caused compensatory up-regulation of others. Upon simultaneous gene-silencing using n-siRNAFAK+NOTCH-1+SOX-2, ~ 90% GSCs underwent cell death and lost their ability to form GBM neurospheres, whereas normal stem cells remained unaffected while retaining neuronal differentiation capacity. GSCs derived from glioblastoma patients (n=4) showed inability to form neurospheres post nanoparticle treatment whereas the clinical drug; temozolomide, had little effect, indicating the clinical significance of NPG-based treatment. GBM patient derived xenograft (PDX) models exhibiting the characteristics of patient samples also showed significant impairment in the tumorigenic potential of nanoparticle-treated GSCs. In effect, this thesis investigation shows that locally injectable n-siRNA NPG targeted to multiple stem-cell signaling can impair the glioma initiation capabilities of GSCs. newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced